Related Experiment Video
Updated: Aug 12, 2026
12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
T-cell-rich B-cell lymphoma in a cat
K E Steele1, G K Saunders, G D Coleman
1Pathology Division, USAMRIID, Fort Detrick, Frederick, MD 21702-5011, USA.
Veterinary Pathology
|January 1, 1997
Summary
A feline T-cell-rich B-cell lymphoma (TRBCL) was identified in a cat with a parotid gland mass. This rare cancer mirrors the human form, featuring large B-cells among small T-cells.
Area of Science:
- Veterinary Pathology
- Oncology
- Immunohistochemistry
Background:
- T-cell-rich B-cell lymphoma (TRBCL) is a human neoplasm characterized by large B lymphocytes and reactive T lymphocytes.
- Feline neoplasms require detailed characterization to improve diagnostic accuracy and treatment strategies.
Observation:
- A 13-year-old Domestic Shorthair cat presented with a parotid gland mass.
- Histological examination revealed large atypical cells within a background of small lymphoid cells.
- Immunohistochemical analysis identified the large cells as B-lymphocytes (BLA.36+) and the small cells as T-lymphocytes (CD3+).
Findings:
- The feline parotid gland mass exhibited histomorphologic and immunohistochemical characteristics consistent with T-cell-rich B-cell lymphoma.
- This represents a unique feline neoplasm mirroring a specific human lymphoma subtype.
Implications:
- This case expands the understanding of B-cell neoplasms in felines.
- The findings support the use of feline models for studying human lymphomas.
- Further research into feline TRBCL could inform diagnostic and therapeutic strategies in both veterinary and human medicine.
